You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4201 to 4225 of about 5936
Next 25
11/22/2006
Initial experiences of palliative stereotactic radiosurgery for recurrent brain lymphomas.
Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions.
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme
Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts
The course of neurocognitive functioning in high-grade glioma patients
Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol)
The pathophysiologic mechanism of cerebellar mutism.
11/21/2006
University Evaluates New Device To Treat Brain Tumors
11/20/2006
Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting
NEOPHARM AnNOUNCES Presentation of FINAL SAFETY DATA FROM PHASE 1 TRIAL OF CINTREDEKIN BESUDOTOX for Newly Diagnosed Malignant Glioma
11/19/2006
Celtic Pharma and Neurobiological Technologies Present an Update on XERECEPT(R) for Peritumoral Brain Edema at the 11th Annual Meeting of the Society For Neuro-Oncology
11/18/2006
Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer
NCI Best Case Series for CAM: Outcomes in Treatment of Brain Tumors
Vaccine for brain tumors shows promising results
11/10/2006
Reata Announces Presentation of Interim Results for Phase 1 Study of RTA 744 in Treatment of Advanced Brain Tumors
Anti-cancer virus kills brain cancer cells
Jefferson Oncologists Show Less Radiation Just as Effective in Fighting Brain Tumor, Saving Hearing
A lesson in Living
Northwest Biotherapeutics Discusses Results From Clinical Trials In Brain Cancer At Two Conferences
Newly identified biomarker detects and regulates spread of brain tumors
Neurospheres Enriched in Cancer Stem-Like Cells Are Highly Effective in Eliciting a Dendritic Cell-Mediated Immune Response against Malignant Gliomas.
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.